Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test

2010 ◽  
Vol 30 (5) ◽  
pp. 717-723 ◽  
Author(s):  
Claudia Feitosa-Santana ◽  
Galina V. Paramei ◽  
Mauro Nishi ◽  
Mirella Gualtieri ◽  
Marcelo F. Costa ◽  
...  
2006 ◽  
Vol 23 (3-4) ◽  
pp. 663-668 ◽  
Author(s):  
CLAUDIA FEITOSA-SANTANA ◽  
NESTOR N. OIWA ◽  
GALINA V. PARAMEI ◽  
DAVID BIMLER ◽  
MARCELO F. COSTA ◽  
...  

Color vision impairment was examined in patients with type 2 diabetes mellitus (DM2) without retinopathy. We assessed the type and degree of distortions of individual color spaces. DM2 patients (n= 32), and age-matched controls (n= 20) were tested using the Farnsworth D-15 and the Lanthony D-15d tests. In addition, subsets of caps from both tests were employed in a triadic procedure (Bimler & Kirkland, 2004). Matrices of inter-cap subjective dissimilarities were estimated from each subject's “odd-one-out” choices, and processed using non-metric multidimensional scaling. Two-dimensional color spaces, individual and group (DM2 patients; controls), were reconstructed, with the axes interpreted as the R/G and B/Y perceptual opponent systems. Compared to controls, patient results were not significant for the D-15 and D-15d. In contrast, in the triadic procedure the residual distances were significantly different compared to controls: right eye,P= 0.021, and left eye,P= 0.022. Color space configurations for the DM2 patients were compressed along the B/Y and R/G dimensions. The present findings agree with earlier studies demonstrating diffuse losses in early stages of DM2. The proposed method of testing uses color spaces to represent discrimination and provides more differentiated quantitative diagnosis, which may be interpreted as the perceptual color system affected. In addition, it enables the detection of very mild color vision impairment that is not captured by the D-15d test. Along with fundoscopy, individual color spaces may serve for monitoring early functional changes and thereby to support a treatment strategy.


2018 ◽  
Vol 66 ◽  
pp. 179-184 ◽  
Author(s):  
Claudia Feitosa-Santana ◽  
Givago da Silva Souza ◽  
Esaú Ventura Pupo Sirius ◽  
Anderson Raiol Rodrigues ◽  
Maria Izabel Tentes Cortes ◽  
...  

2008 ◽  
Vol 83 (1) ◽  
pp. 148-149
Author(s):  
Marcelo Fernandes Costa ◽  
Andre Gustavo Fernandes Oliveira ◽  
Claudia Feitosa-Santana ◽  
Mayana Zatz ◽  
Dora Fix Ventura

2018 ◽  
Vol 32 (6) ◽  
pp. 601-606
Author(s):  
Sonia Wagner ◽  
Miguel Rioseco ◽  
Duniel Ortuño ◽  
María F. Cortés ◽  
Carolina Costa

2019 ◽  
Vol 40 (9) ◽  
pp. 1939-1942 ◽  
Author(s):  
Anna Piro ◽  
Antonio Tagarelli ◽  
Paolo Lagonia ◽  
Giuseppe Nicoletti ◽  
Aldo Quattrone

2015 ◽  
Vol 262 (11) ◽  
pp. 2491-2497 ◽  
Author(s):  
E. J. Lampert ◽  
M. Andorra ◽  
R. Torres-Torres ◽  
S. Ortiz-Pérez ◽  
S. Llufriu ◽  
...  

2018 ◽  
Vol 31 (2) ◽  
pp. 97-102 ◽  
Author(s):  
Patrick M. Flanigan ◽  
Mitra A. Khosravi ◽  
James B. Leverenz ◽  
Babak Tousi

Objective: Dementia with Lewy bodies (DLB) is frequently misdiagnosed for Alzheimer dementia (AD), especially in its earlier stages. We characterized color vision impairment (CVI) in patients with DLB versus patients with AD to determine its usefulness in improving accuracy of early diagnosis. Methods: We retrospectively reviewed charts of patients with AD, DLB, and patients with mild cognitive impairment suspected to be in the prodromal phase of DLB (pro-DLB) or prodromal phase of AD (pro-AD). All patients underwent an online 15-hue color vision arrangement test. Results: Fifty-two patients were included in this study with a median age of 77 years, of which 44% were female. No significant differences in gender, age, or Montreal Cognitive Assessment existed among patients with AD (n = 15), pro-AD (n = 5), pro-DLB (n = 8), and DLB (n = 24). Of the 52 patients, 4 (2 AD, 1 DLB, and 1 pro-AD) had CVI history from a young age and were excluded from final analyses. New-onset CVI prevalence differed significantly based on diagnosis: patients with pro-AD (20%), patients with AD (15%), patients with pro-DLB (38%), and patients with DLB (78%, P < .001). In a stepwise multivariate logistic regression analysis to determine factors associated with CVI, “diagnosis type” as a binary variable (DLB or pro-DLB vs AD or pro-AD) was the only variable retained in the model (odds ratio = 9.8 [95% CI: 2.3-42.1], P < .001). Conclusions: Color vision impairment in patients with DLB showed a prevalence similar to the core features of DLB (∼80%) and can be supportive to a diagnosis of DLB versus AD. Pending prospective confirmation of our findings, simple online color vision testing could be incorporated into multivariate diagnostic tools to possibly improve accuracy of early diagnosis of DLB.


Sign in / Sign up

Export Citation Format

Share Document